The U.S. Drug Administration approves the new crown vaccine booster for certain people with low immunity

According to the news from the Xinhua News Agency on the 13th, the US Food and Drug Administration announced on the 12th that it approved certain people with low immunity to receive a booster shot of the new crown vaccine.

The US Drug Administration approved the booster shots of Pfizer vaccine and Modena vaccine this time, and the routine vaccination schedule for both vaccines is two doses. The U.S. Drug Administration issued a statement saying that certain people with low immunity, especially organ transplant recipients, can receive booster shots of the same vaccine at least 28 days after the completion of the two doses.

Several small studies cited by the US Centers for Disease Control and Prevention have shown that for people who have a poor immune response after vaccination, the new crown vaccine booster may help their immune system to produce antibodies.